Revolutionary breakthrough: FDA approves CASGEVY, the first CRISPR/Cas9 gene therapy for sickle cell diseaseAjeet Singh, Aymar Akilimali, Zainab Nazir et al.|Annals of Medicine and Surgery|2024Cited by 87
Omalizumab for the reduction of allergic reactions to foods: a narrative reviewHafsa Ghouri, Aymar Akilimali, Zainab Nazir et al.|Frontiers in Allergy|2024Cited by 10
Unveiling Pakistan’s transport problems: a call to safeguard public healthAshna Habib, Aymar Akilimali, Tooba Ali et al.|Frontiers in Public Health|2024Cited by 3
Rising rates of conjunctivitis in Pakistan: epidemic, challenges, solutions, and recommendationsAshna Habib, Aymar Akilimali, Tooba Ali et al.|International Journal of Surgery Global Health|2024Cited by 1